Adjusted EBITDA improved significantly to $-16.2 million compared to $-43.9 million in Q1 2024, representing a $27.8 million ...

Live Updates Live Coverage Has Ended Tempus AI sentiment heading 3:43 pm by Tempus enters earnings with strong tailwinds but ...

CHICAGO (AP) — CHICAGO (AP) — Tempus AI Inc. (TEM) on Tuesday reported a loss of $68 million in its first quarter. On a per-share basis, the Chicago-based company said it had a loss of 40 cents.

Tempus is a data-driven precision medicine company bringing the power of data and artificial intelligence to healthcare. Tempus is a technology company advancing precision medicine through the ...

The firm's Genomics revenues increased 89 percent, while Data and Services revenues rose 43 percent year over year.

The latest price target for Tempus AI (NASDAQ:TEM) was reported by Needham on April 24, 2025. The analyst firm set a price target for $70.00 expecting TEM to rise to within 12 months (a possible ...

When it comes to shares of Tempus AI (NASDAQ: TEM), many may feel like they're standing on a dock watching the stock sail off to the horizon.It's understandable if you identify with this. After ...

Tempus AI stock price remains in a deep bear market as investors worry that the hype that drove it to a record high was ending. The TEM stock initially peaked at $91.40 in February, and has now ...

Tempus AI TEM and Doximity DOCS stand out as emerging players in the AI health tech space. These two offer distinct approaches to innovation and market disruption. Tempus AI is focused on ...